Page 142 - Case Lab Case Analysis
P. 142
2012
Heather Bresch becomes CEO – claims EpiPen as ‘her baby’
Previously Bresch was appointed President of Mylan in 2009
and joined Mylan's Board in March 2011
2013
New strategy for EpiPen introduced based on advocacy and
marketing
2013
Price of two pac of EpiPen rises to $265 from $100 in 2009
2015
May witnesses a 2pac EpiPen price rise to $461
2015
Marketshare for EpiPens 85% with sales of $1.5bn
